This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Pfizer briefed EU merger regulator on $43 billion Seagan buyout

( April 17, 2023, 07:15 GMT | Official Statement) -- MLex Summary: Pfizer briefed the EU's merger regulator about its planned $43 billion acquisition of Seagan earlier this month, according to a corporate filing. Seagan said the European Commission would formally review the deal only if requested to do so by other European competition authorities. It said the merger was also conditional on receiving approval from the UK's merger regulator if it decides to call it in.An extract from the corporate filing follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login